MedPath

A randomized double-blind placebo-controlled trial for improving the intestinal environment in huma

Not Applicable
Conditions
Healthy adults
Registration Number
JPRN-UMIN000022760
Lead Sponsor
ORTHOMEDICO, Inc.
Brief Summary

Hoshino T, Yamashita S, Suzuki N, Takara T. Effects of Food Containing Resistant Dextrin and Galactooligosaccharides on the Intestinal Environment in Healthy Japanese Adults. -A Randomized, Double-blind, Placebo-controlled, Parallel-group Trial-. Jpn Pharmacol Ther. 2018; 46(10): 1707-1722

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1. Subjects who have at least one previous medical history of malignant tumor, heart failure or myocardial infarction 2. Subjects who being treated for at least one of following diseases: cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension or other chronic diseases 3. Subjects who currently take medicines (include herbal medicines) 4. Subjects who currently take Food for Specified Health Uses, Foods with Functional Claims, yogurt, and/or lactic fermenting beverage 5. Subjects who are allergic to medicines or foods related to the test food of this trial 6. Subjects who currently take supplements or fortified foods 7. Subjects who are pregnant, lactating, or planning to get pregnant during the trial period 8. Subjects who have enrolled into other clinical trials within the last 3 months before agreeing to participate in this trial 9. Subjects are judged as unsuitable for participating in this trial by physician for other reasons

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Enterobacterial flora (Bifidobacterium, Lactobacillales, Bacteroides, Prevotella, Clostridium cluster IV, Clostridium cluster IX, Clostridium cluster XI, Clostridium cluster XVIII, Clostridium subcluster XIVa, and others) *1 Perform the test at 0 week and at 1 and 2 weeks after the ingestion
Secondary Outcome Measures
NameTimeMethod
1. The Japanese version of Constipation Assessment Scale MT version (CAS-MT) *1 Perform the test at 0 week and at 1 and 2 weeks after the ingestion 2. Stool form scale *2 Perform the test at 0 week and at 1 and 2 weeks after the ingestion 3. Bowel movement diary *3 Recording about the defecation every day
© Copyright 2025. All Rights Reserved by MedPath